EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virtual Screening Approaches to Identify Promising Multitarget-Directed Ligands for the Treatment of Autism Spectrum Disorder

Jakub Jończyk iD, Klaudia Przybylska, Marek Staszewski iD, Justyna Godyń iD, Tobias Werner iD, Monika Stefaniak-Napieralska iD, Holger Stark iD, Krzysztof Walczyński iD, Marek Bajda iD

Molecules · 2024

DOI: 10.3390/molecules29225271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Jakub Jończyk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Kraków, Poland. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Molecular Docking Simulation, Receptors, Histamine H3. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jagiellonian University Medical College, European Union's Horizon 2020, Foundation for Polish Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder is a complex neurodevelopmental disorder. The available medical treatment options for autism spectrum disorder are very limited. While the etiology and pathophysiology of autism spectrum disorder are still not fully understood, recent studies have suggested that wide alterations in the GABAergic, glutamatergic, cholinergic, and serotonergic systems play a key role in its development and progression. Histamine neurotransmission is known to have complex interactions with other neurotransmitters that fit perfectly into the complex etiology of this disease. Multitarget-directed compounds with an affinity for the histamine H3 receptor indicate an interesting profile of activity against autism spectrum disorder in animal models. Here, we present the results of our research on the properties of (4-piperazin-1-ylbutyl)guanidine derivatives acting on histamine H3 receptors as potential multitarget ligands. Through the virtual screening approach, we identified promising ligands among 32 non-imidazole histamine H3 receptor antagonists/inverse agonists with potential additional activity against the dopamine D2 receptor and/or cholinesterases. The virtual screening protocol integrated predictions from SwissTargetPrediction, SEA, and PPB2 tools, along with molecular docking simulations conducted using GOLD 5.3 and Glide 7.5 software. Among the selected ligands, compounds 25 and 30 blocked radioligand binding to the D2 receptor at over 50% at a screening concentration of 1 µM. Further experiments allowed us to determine the pKi value at the D2 receptor of 6.22 and 6.12 for compounds 25 and 30, respectively. Our findings suggest that some of the tested compounds could be promising multitarget-directed ligands for the further research and development of more effective treatments for autism spectrum disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderMolecular Docking SimulationReceptors, Histamine H3LigandsHumansDrug Evaluation, PreclinicalHistamine H3 AntagonistsReceptors, Dopamine D2

Stichwörter der Autor:innen

autism spectrum disordercholinesterasesdopamine receptorshistamine H3 receptormultitarget-directed ligandsvirtual screening

Substanzen

LigandsReceptors, Histamine H3Histamine H3 AntagonistsReceptors, Dopamine D2

Autor:innen und Institutionen

  • Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Kraków, Poland.
  • Sano-Centre for Computational Medicine, 30-054 Kraków, Poland.
  • Department of Synthesis and Technology of Drugs, Faculty of Pharmacy, Medical University of Lodz, 90-151 Lodz, Poland.
  • Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, 40225 Düsseldorf, Germany.

ORCID-Profile: Jakub Jończyk, Marek Staszewski, Justyna Godyń, Tobias Werner, Monika Stefaniak-Napieralska, Holger Stark, Krzysztof Walczyński, Marek Bajda

Förderung

  • Jagiellonian University Medical College
  • European Union's Horizon 2020
  • Foundation for Polish Science
  • European Union’s Horizon

Zitieren

APA

Jończyk, J., Przybylska, K., Staszewski, M., Godyń, J., Werner, T., Stefaniak-Napieralska, M., Stark, H., Walczyński, K., & Bajda, M. (2024). Virtual Screening Approaches to Identify Promising Multitarget-Directed Ligands for the Treatment of Autism Spectrum Disorder. Molecules. https://doi.org/10.3390/molecules29225271

Vancouver

Jończyk J, Przybylska K, Staszewski M, Godyń J, Werner T, Stefaniak-Napieralska M, et al. Virtual Screening Approaches to Identify Promising Multitarget-Directed Ligands for the Treatment of Autism Spectrum Disorder. Molecules. 2024. doi:10.3390/molecules29225271

BibTeX
@article{Joczyk2024,
  author = {Jończyk, Jakub and Przybylska, Klaudia and Staszewski, Marek and Godyń, Justyna and Werner, Tobias and Stefaniak-Napieralska, Monika and Stark, Holger and Walczyński, Krzysztof and Bajda, Marek},
  title = {Virtual Screening Approaches to Identify Promising Multitarget-Directed Ligands for the Treatment of Autism Spectrum Disorder},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29225271}
}
Kostenlos starten →